Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Jenna McCracken"'
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:e310-e313
Introduction Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) occasionally undergoes Richter transformation, mostly to diffuse large B-cell lymphoma, but its evolution to other types of B-cell lymphoma is rare. We report a CLL evolve
Publikováno v:
Hematological Oncology. 40:112-115
Autor:
Catherine Luedke, Jerald Z. Gong, Lian-He Yang, Yue Zhao, Rachel Jug, Jenna McCracken, Jonathan Galeotti, Jake Maule, Imran Siddiqi, Endi Wang, Chuanyi M. Lu
Publikováno v:
Journal of Clinical Pathology. 75:292-301
AimsMyeloid neoplasms occur in the setting of chronic lymphocytic leukaemia (CLL)/CLL-like disease. The underlying pathogenesis has not been elucidated.MethodsRetrospectively analysed 66 cases of myeloid neoplasms in patients with CLL/CLL-like diseas
Publikováno v:
Journal of Hematopathology. 14:251-253
Autor:
Endi Wang, Cathrine Rehder, Jenna McCracken, Yue Zhao, Deepti M. Reddi, Natasha Iranzad, Jadee L. Neff
Publikováno v:
Archives of pathologylaboratory medicine. 146(6)
Context.— Concomitant BCR-ABL1 and JAK2V617F in myeloproliferative neoplasms (MPNs) is rare, and its pathogenesis and clinical significance are unclear. Objective.— To investigate the clonal relationship between the 2 genomic alterations, as well
Publikováno v:
Pathology - Research and Practice. 216:152818
Splenosis refers to ectopic splenic implants that are often found incidentally years after splenic rupture/splenectomy, and the nodules of splenosis are usually small, less than 3 cm for the majority. We report a case of splenosis with a 5-centimeter
Publikováno v:
American Journal of Clinical Pathology. 152:S111-S111
Introduction Plasma cell neoplasm (PCN) is rarely associated with Waldenstrom macroglobulinemia (WM)/lymphoplasmacytic lymphoma (LPL), and its clonal relationship to WM/LPL is unclear. Methods We retrospectively analyzed five cases of PCN concomitant
Publikováno v:
Health Science Reports
Background Lynch syndrome (LS) accounts for 5% of all endometrial cancer (EC) cases and 4% of all lifetime risk of developing colorectal cancer. While current guidelines recommend LS screening for all patients with newly diagnosed colorectal cancer,